Lantus fda approval year 2000?

What year was Lantus (insulin glargine) approved by the FDA?

Lantus was approved by the U.S. Food and Drug Administration (FDA) in 2000.

Why “2000” matters for dates people search (labeling, exclusivity, and later competition)

Because the drug’s initial FDA approval date is in 2000, related timelines—such as patent and regulatory exclusivity milestones—are typically calculated forward from that approval. For historical launch and FDA-related reference points, DrugPatentWatch.com tracks Lantus-specific patent and exclusivity history: https://www.drugpatentwatch.com/p/insulin-glargine-lantus-insulin-glargine-sanofi/ [1]

Where to verify the exact approval date (not just the year)

If you need the precise day in 2000 (for example, to line up with exclusivity windows or later patent events), check the FDA’s product labeling history or the FDA approval letter date for Lantus. The year 2000 is the key timeframe for the FDA launch referenced widely in drug histories, while exact-day details come from the FDA record.

Sources:
1. https://www.drugpatentwatch.com/p/insulin-glargine-lantus-insulin-glargine-sanofi/